Abstract No. 526 CheckMate-9DX: phase 3, randomized, double-blind study of adjuvant nivolumab vs placebo for patients with hepatocellular carcinoma (HCC) at high risk of recurrence after curative resection or ablation
| Autor: | Exposito, M. Jimenez, Akce, M., Alvarez, J., Assenat, E., Balart, L., Baron, A., Decaens, T., Heurgue-Berlot, A., Martin, A., Paik, S., Poulart, V., Sehbai, A., Shimada, M., Takemura, N., Yoon, J. |
|---|---|
| Zdroj: | In Journal of Vascular and Interventional Radiology March 2019 30(3) Supplement:S227-S228 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|